Sparkneuro
1 known investors
SPARK provides dementia diagnosis support, identifying high-risk members early and offering comprehensive cognitive evaluations to enable earlier intervention. It uses dementia specialists to reduce the workload on primary care physicians, targeting patients and providers in the U.S. dementia care market.
Digital HealthHealthtechMedical Devices
Investors · 1
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.3M |
| U.S. Air ForceAir Force | Phase IISTTR | 2022 | $2.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2022 | $299.8K |
| U.S. Air ForceAir Force | Phase ISTTR | 2021 | $50K |
| U.S. Air ForceAir Force | Phase II | 2020 | $1000K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Sparkneuro do?
- SPARK provides dementia diagnosis support, identifying high-risk members early and offering comprehensive cognitive evaluations to enable earlier intervention. It uses dementia specialists to reduce the workload on primary care physicians, targeting patients and providers in the U.S. dementia care market.
- Who are Sparkneuro's investors?
- Sparkneuro's investors include Connectivity Ventures.